REP 160 Pill: blue, capsule/oblong
Generic Name: repotrectinib
The pill with imprint REP 160 (Blue, Capsule/Oblong, 0mm) has been identified as Augtyro 160 mg and is used for Non Small Cell Lung Cancer, and Solid Tumors. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for REP 160
Augtyro
- Generic Name
- repotrectinib
- Imprint
- REP 160
- Strength
- 160 mg
- Color
- Blue (opaque)
- Shape
- Capsule/Oblong (capsule)
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-4160
See also:
More about Augtyro (repotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.